In humans, FOXL2 also serves as an early granulosa cell marker and FOXL2 mutations have been associated with premature ovarian failure (Zlotogora et al., 1983; Duffin et al., 2009; Garcia-Alonso et al., 2022). The gene discussed is FOXL2; the disease is primary ovarian failure.